From July 1, 2023 to September 30, 2023, the company has repurchased 40,000 shares, representing 2.8% for $0.19 million. With this, the company has completed the repurchase of 40,000 shares, representing 2.8% for $0.19 million under the buyback announced on June 12, 2023.
Creative Medical Technology Holdings, Inc.
Equities
CELZ
US22529Y4089
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.32 USD | -1.82% | -10.19% | -6.29% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.29% | 5.86M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CELZ Stock
- News Creative Medical Technology Holdings, Inc.
- Tranche Update on Creative Medical Technology Holdings, Inc.'s Equity Buyback Plan announced on June 12, 2023.